When is CT-based postoperative seroma most useful to plan partial breast radiotherapy? Evaluation of clinical factors affecting seroma volume and clarity

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1064-9. doi: 10.1016/j.ijrobp.2008.02.049. Epub 2008 Apr 12.

Abstract

Purpose: To evaluate the effect of the time from surgery and other clinical factors on seroma volume and clarity and establish the optimal time to use the computed tomography (CT)-based seroma to plan partial breast irradiation (PBI).

Methods and materials: A total of 205 women with early-stage breast cancer underwent planning CT after breast-conserving surgery. One radiation oncologist contoured the seroma volume and scored the seroma clarity, using a standardized Seroma Clarity Score scale, from 0 (not detectable) to 5 (clearest). Univariate and multivariate analyses were performed to evaluate the associations between the seroma characteristics and the interval from surgery and other clinical factors.

Results: The mean interval from surgery to CT was 84 days (standard deviation 59). During postoperative Weeks 3-8, the mean seroma volume decreased from 47 to 30 cm(3), stabilized during Weeks 9-14 (mean 21) and was involuted beyond 14 weeks (mean 9 cm(3)). The mean seroma clarity score was 3.4 at Weeks 3-8, 2.5 at Weeks 9-14, and 1.6 after 14 weeks. The seroma clarity was greater in patients aged >or=70 years. The seroma volume and clarity correlated significantly with the volume of excised breast tissue but not with the maximal tumor diameter, surgical re-excision, or chemotherapy use.

Conclusion: The optimal time to obtain the planning CT scan for PBI is within 8 weeks after surgery. During Weeks 9-14, the seroma might remain adequately defined in some patients; however, after 14 weeks, alternate strategies are needed to identify the PBI target. The lack of correlation between the seroma volume and tumor size suggests that the CT-based seroma should not be the sole guide for PBI target volume definition.

Publication types

  • Clinical Trial

MeSH terms

  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / radiotherapy*
  • Breast Neoplasms / surgery
  • British Columbia / epidemiology
  • Female
  • Humans
  • Imaging, Three-Dimensional / methods
  • Mastectomy
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnostic imaging*
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / radiotherapy*
  • Patient Selection
  • Prognosis
  • Radiotherapy, Adjuvant / methods
  • Radiotherapy, Computer-Assisted / statistics & numerical data
  • Risk Assessment / methods*
  • Risk Factors
  • Seroma / diagnostic imaging*
  • Seroma / epidemiology
  • Seroma / radiotherapy*
  • Tomography, X-Ray Computed / methods*
  • Treatment Outcome